Literature DB >> 16785851

Conivaptan (Vaprisol) for hyponatremia.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16785851

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  2 in total

1.  Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema.

Authors:  Emil Zeynalov; Susan M Jones; J Paul Elliott
Journal:  J Vis Exp       Date:  2016-09-01       Impact factor: 1.355

2.  Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.

Authors:  Emil Zeynalov; Susan M Jones; Jeong-Woo Seo; Lawrence D Snell; J Paul Elliott
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.